TrialBritish journal of cancer2024

COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer.

Neil H Segal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.